Lipid Blood Profile in Old Patients With Ischemic Heart Disease

Purpose: to assess prevalence of dyslipidemia in patients with ischemic heart disease (IHD) older than 75 years as well as to evaluate possible associations between serum lipids and various cardiovascular and other diseases in these patients. Methods. We enrolled in this cross sectional study 555 hospitalized IHD patients aged 75-98 years (mean age 86.8 years, 74.5% women). Levels of lipids (total cholesterol [TC], triglycerides [TG], low and high-density lipoprotein cholesterol [LDLC, HDLC]) were measured by enzyme method on the biochemistry analyzer Konelab 60i. Results. Elevated TC; hypertriglyceridemia and elevated LDLC were observed in 13.3, 10.4 and 26.3% of patients, respectively. In the majority of patients severity of dyslipidemia was mild. With increasing age serum levels of TC and LDLC decreased. Negative correlation between TC level and patient’s age was significant (r= -0.13; p=0.001). Mean TC level was 5.43, 5.0 and 4.7 mmol/l in patients aged <80 (group 1), 80-89 (group 2), and >90 (group 3) years, respectively (p=0.001 for differences between groups 1-and 3). Similar results were registered in respect of LDLC: mean LDLC level was 3.7 and 2.7 mmol/l in groups 1 and 3, respectively (p=0.004). Mean concentrations of all lipids in women were higher than in men: TC 5.1 vs 4.5 (p<0.0001), LDLC 3.1 vs 2.5 (p=0.0002), HDLC - 1.26 vs 1.17 mmol/l (p=0.01). Lower lipids levels (especially those of TC) were significantly associated with clinically significant heart failure (p<0.0001) and atrial fibrillation (p<0.0001). Higher TC and TG correlated positively with higher systolic and diastolic blood pressure (p=0.001). Significant positive correlations existed between TG and glucose concentration (p<0.0001) as well as between TG and uric acid level (p=0.001). Higher TG and lower HDLC levels were registered in patients with higher creatinine level (p=0.001 and 0.0003, respectively). Only 11.4% of study patients received statins. Conclusion. The study results evidence for considerable peculiarities of lipid profile in the very elderly patients with IHD. Significant associations between dyslipidemia and a number of diseases were also revealed.

ischemic heart disease, lipid profile, cholesterol, old age, cardiovascular diseases

1. Демографический ежегодник России. 2015: Стат. сб./Росстат. - M., 2015. -263 с.

2. Takata Y., Ansai T., Soh I. et al. Serum total cholesterol concentration and 10-year mortality in an 85-year-old population. Clin Intervent Aging 2014;9:293-300.

3. Felix-Redondo F.J., Grau M., Fernandez-Berges D. Cholesterol and Cardiovascular Disease in the Elderly. Facts and Gaps. Aging and Disease 2013;4 (3):154-169.

4. Cabrera M. A. S., de Andrade S. M., Dip R. M. Lipids and All-Cause Mortality among OlderAdults:A12-Year Follow-Up Study. Scientific World J 2012; 2012: 930139. D0I:10.1100/2012/930139

5. Bathum L., Christensen R. D., Pedersen L. E. et al. Association of lipoprotein levels with mortality in subjects aged 50 ± without previous diabetes or cardiovascular disease: A population-based register study. Scand J Prim Health Care 2013;31 (3):172-180. DOI: 10.3109/02813432.2013.824157

6. Schatz I.J., Masaki K., Yano K. et al. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001;358 (9279):351-355.

7. Newschaffer C.J., Bush T. L., Hale W. E. Aging and Total Cholesterol Levels: Cohort, Period, and Survivorship Effects. Am J Epidemiol 1992;136:23-34.

8. Upmeier E., Lavonius S., Heinonen P. et al. Longitudinal changes in serum lipids in older people the Turku elderly study 1991-2006. Age Ageing 2011;40 (2):280-283. DOI: 10.1093/ageing/afq180

9. Ravnskov U., Diamond D. M., Hama R. et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open 2016;6: e010401. DOI: 10.1136/bmjopen-2015-010401

10. Ahmadi S.-F., Streja E., Zahmatkesh G. et al. Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. JAMDA 2015;16:933-939.

11. Antikainena R., Strandbergb T., Barbagalloc M. et al. Paradoxes in the old age-reverse epidemiology. Eur Geriatric Med 2012;3S: S10-S11.

12. Swiger K., Martin S., Blaha M. et al. Atherogenic lipid levels in 662,711 elderly persons: the very large database of lipids 10A (VLDL 10A). J Am Coll Cardiol 2014;63 (12S): A1459. DOI: 10.1016/S0735-1097 (14) 61459-5

13. Crook D., Stevenson J. C. CHD in women - are serum lipids and lipoproteins important? In: Betteridge D.J. ed. Lipids: current perspective. London: Martin Dunitz Ltd 1996:171-183.

14. Marhoum T. A., Abdrabo A. A., Lutfi M. F. Effects of age and gender on serum lipid profile in over 55 years-old apparently healthy Sudanese individuals. Asian J Biomed Pharmaceutical Scie 2013;3 (19):10-14.

15. Charach G., Rabinovich A., Ori A. et al. Low levels of low-density lipoprotein cholesterol: a negative predictor of survival in elderly patients with advanced heart failure. Cardiology 2014;127 (1):45-50. DOI: 10.1159/000355164

16. Charach G., George J. LDL-Cholesterol and outcome prediction in patients with congestive heart failure. J Cardiol Curr Res 2014;1 (2):0007. DOI: 10.15406/jccr. 2014.01.00007

17. Fonarow G. C., Horwich T. B. Cholesterol and Mortality in Heart Failure: The Bad Gone Good? J Am Coll Cardiol 2003;42 (11):1941-1943. DOI:10.1016/j. jacc. 2003.09.005

18. Horwich T. B., Hamilton M. A., Maclellan W. R., Fonarow G. C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Cardiol Fail 2002;8 (4):216-224.

19. Annoura M., Ogawa M., Kumagai K. et al. Cholesterol paradox in patients with paroxysmal atrial fibrillation. Cardiology 1999;92 (1):21-27.

20. Watanabe H., Tanabe N., Yagihara N. et al. Association Between Lipid Profile and Risk of Atrial Fibrillation. Niigata Preventive Medicine Study. Circ J 2011;75: 767-2774.

21. Suzuki S. “Cholesterol paradox" in atrial fibrillation. Circ J 2011;75 (12):2749-2750.

22. Lopez F. L., Agarwal S. K., Maclehose R. F. et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol 2012;5 ( 1 ): 155-162. DOI: 10.1161/CIRCEP. 111.966804

23. Miller M., Stone N.J., Ballantyne C. et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123 (20):2292-2333. DOI: 10.1161/CIR. 0b013e3182160726

24. Krauss R. M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004;27 (6):1496-1504.

25. Peng T.-C., Wang C.-C., Kao T.-W. et al. Relationship between hyperuricemia and lipid profiles in US adults. BioMed Res Int 2015;2015:127596. DOI: 10.1155/2015/127596.

26. Lippi G., Montagnana M., Luca Salvagno G. et al. Epidemiological association between uric acid concentration in plasma, lipoprotein (a), and the traditional lipid profile. Clin Cardiol 2010;33 (2):E76-80. DOI: 10.1002/clc. 20511

27. De Oliveira E. P., Burini R. C. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 2012;4:12. DOI: 10.1186/1758-5996-4-12

28. Tsimihodimos V., Mitrogianni Z., Elisaf M. Dyslipidemia Associated with Chronic Kidney Disease. Open Cardiovasc Med J 2011;5:41-DOI: 10.2174/1874192401105010041

29. Stone N.J., RobinsonJ. G., Lichtenstein A. H. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63 (25):2889-2934. DOI: 10.1016/j. jacc. 2013.11.002